Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹47 Cr.
Stock P/E
8.4
P/B
2.3
Current Price
₹41.5
Book Value
₹ 18.2
Face Value
10
52W High
₹99
52W Low
₹ 38.2
Dividend Yield
0%

ABH Healthcare Overview

Business

ABH Healthcare Ltd. operates in the Hospital & Healthcare Services sector in India. Its core business model revolves around providing comprehensive medical services, including inpatient care, outpatient consultations, diagnostic services, surgical procedures, and specialty treatments. The company generates revenue primarily through fees charged to patients for medical services, which can be paid out-of-pocket, through health insurance providers, or via corporate tie-ups and government healthcare schemes. It aims to deliver quality healthcare facilities and medical expertise to a diverse patient base.

Revenue Mix

While specific revenue contribution breakdown for ABH Healthcare Ltd. is not publicly available without detailed financial reports, typical revenue segments for a multi-specialty hospital chain in India include:

Inpatient Services: Revenue from patients admitted for treatment, surgeries, and extended care. This often forms a significant portion.

Outpatient Services: Consultations, minor procedures, and follow-ups.

Diagnostic Services: Radiology (X-rays, CT scans, MRIs), pathology (blood tests, biopsies), and other lab services.

Pharmacy Services: Revenue from medicines dispensed within the hospital premises.

Specialty Clinics: Dedicated revenue streams from specialized departments like cardiology, oncology, orthopedics, neurology, etc.

Industry

The Indian Hospital & Healthcare Services industry is characterized by robust growth, driven by a large and growing population, increasing disposable incomes, rising health awareness, and a growing burden of lifestyle diseases. It is a mix of highly fragmented local providers and increasingly consolidated regional/national hospital chains. Public healthcare infrastructure supplements private players. ABH Healthcare Ltd. operates within this competitive landscape, likely positioning itself as a provider of quality medical care. Its specific positioning (e.g., premium, mid-market, multi-specialty, single-specialty, regional focus) would depend on its scale of operations, geographical footprint, and service offerings relative to larger, established national players and smaller, localized hospitals.

MOAT

ABH Healthcare's competitive advantages (moats) would depend on its specific operations and market standing. Potential moats in the healthcare sector include:

Brand Reputation & Trust: A strong reputation built on patient outcomes, ethical practices, and experienced medical professionals can create significant patient loyalty.

Doctor Talent & Expertise: The ability to attract and retain highly skilled and renowned doctors, surgeons, and specialists is a key differentiator.

Specialized Infrastructure: Investments in advanced medical technology and specialty-specific infrastructure (e.g., organ transplant units, advanced oncology centers) can create barriers to entry.

Geographic Density/Network: For larger chains, a network of hospitals across a region can offer scale benefits and patient referral systems.

High Switching Costs (for critical care): Patients often stick with a hospital or doctor for complex or long-term treatments due to continuity of care and trust.

For a company like ABH, its specific moat would likely stem from its regional brand strength, quality of medical staff, and operational efficiency within its served markets.

Growth Drivers

Key factors that can drive growth for ABH Healthcare over the next 3-5 years include:

Rising Healthcare Demand: Driven by population growth, aging demographics, increasing prevalence of chronic diseases, and greater health awareness in India.

Increased Insurance Penetration: Growing adoption of private health insurance and government schemes like Ayushman Bharat will increase affordability and access to private healthcare.

Medical Tourism: For quality private hospitals, attracting international patients seeking cost-effective, high-quality treatments can be a growth avenue.

Expansion & Capacity Addition: Opening new facilities, adding bed capacity, or expanding into new specialty services in underserved regions.

Technological Advancements: Adoption of new medical technologies, digital health solutions (telemedicine, remote monitoring) to improve efficiency and patient care.

Rising Disposable Incomes: Allowing more individuals to opt for private healthcare facilities.

Risks

ABH Healthcare faces several business risks, including:

Intense Competition: The Indian healthcare market is highly competitive with numerous private and public players, leading to pricing pressures and challenges in attracting patients and talent.

Doctor & Staff Attrition: Shortage of skilled medical professionals and high attrition rates can impact service quality and operational costs.

High Capital Expenditure: Setting up and expanding healthcare facilities requires substantial capital investment, making the business capital-intensive.

Regulatory Changes: Evolving government policies, price controls on procedures/medicines, and accreditation standards can impact profitability and operations.

Medical Malpractice & Litigation Risks: The inherent nature of healthcare carries risks of medical errors and subsequent legal liabilities.

Operational Efficiency: Managing complex hospital operations, optimizing bed occupancy rates, and controlling costs are critical challenges.

Pandemic/Epidemic Risks: Public health crises can significantly impact patient flow, operational costs, and resource allocation.

Management & Ownership

Information regarding the specific promoters, management quality, and ownership structure of ABH Healthcare Ltd. is not available without access to its corporate filings or investor relations documents. Generally, in Indian companies, promoter holding signifies control and long-term vision. Management quality, including the experience and track record of its leadership team (CEO, medical director, CFO), is crucial for strategic direction, operational excellence, and financial performance. A diversified ownership structure, including institutional investors, can indicate broader market confidence and good governance.

Outlook

ABH Healthcare Ltd. operates in a sector with significant tailwinds, driven by India's demographic advantages, increasing healthcare expenditure, and evolving disease patterns. The company stands to benefit from the structural growth of the Indian healthcare market as demand for quality medical services continues to rise. However, the industry is also characterized by intense competition, high capital intensity, and evolving regulatory dynamics. For ABH Healthcare to thrive, it will need to effectively navigate these challenges by focusing on clinical excellence, operational efficiency, judicious expansion, and building a strong brand reputation, especially in its targeted geographic areas and specialties. Its ability to attract and retain top medical talent and adapt to technological advancements will be crucial for sustained growth amidst a dynamic healthcare landscape.

ABH Healthcare Share Price

Live · NSE · Inception: 2021
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

ABH Healthcare Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

ABH Healthcare Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 3 30 41 49 53
Other Income 0 0 0 0 0
Total Income 3 30 41 49 53
Total Expenditure 3 26 34 36 38
Operating Profit 0 4 7 13 15
Interest 0 1 3 4 4
Depreciation 0 2 2 2 2
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 0 1 2 7 8
Provision for Tax 0 0 1 2 2
Profit After Tax 0 1 2 5 6
Adjustments 0 0 0 -0 0
Profit After Adjustments 0 1 2 5 6
Adjusted Earnings Per Share 2.1 0.9 2.1 6.7 7.1

ABH Healthcare Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 0 5 6 12 17
Minority's Interest 0 0 0 0 0
Borrowings 14 14 25 29 48
Other Non-Current Liabilities -0 1 2 2 5
Total Current Liabilities 12 14 19 22 16
Total Liabilities 26 33 52 65 87
Fixed Assets 23 23 34 37 42
Other Non-Current Assets 0 1 0 1 2
Total Current Assets 3 10 18 28 43
Total Assets 26 33 52 65 87

ABH Healthcare Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 0 0 0 0 1
Cash Flow from Operating Activities 3 -2 1 4 2
Cash Flow from Investing Activities -24 -1 -13 -5 -9
Cash Flow from Financing Activities 21 3 12 2 9
Net Cash Inflow / Outflow 0 -0 -0 1 2
Closing Cash & Cash Equivalent 0 0 0 1 3

ABH Healthcare Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 2.13 0.89 2.07 6.67 7.06
CEPS(Rs) 3.92 2.84 4.25 9.31 10.03
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 4.63 5.87 7.94 14.61 21.67
Core EBITDA Margin(%) 6.81 13.67 16.66 26.78 28.03
EBIT Margin(%) 4.75 8.4 12.48 22.61 23.64
Pre Tax Margin(%) 3.51 3.91 5.34 15.08 15.1
PAT Margin (%) 2.43 2.41 4 10.85 10.74
Cash Profit Margin (%) 4.48 7.67 8.21 15.12 15.28
ROA(%) 0.32 2.4 3.89 9.14 7.42
ROE(%) 45.95 29.18 29.97 59.26 38.85
ROCE(%) 0.8 10.7 15.23 23.28 19.71
Receivable days 23.89 37.73 78.82 117.48 183.67
Inventory Days 209.53 26.31 22.71 27.22 26.79
Payable days 3426.49 201.62 168.97 220.05 241.61
PER(x) 0 0 0 0 0
Price/Book(x) 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 5.86 0.77 0.91 0.88 1.14
EV/Core EBITDA(x) 86.09 5.64 5.47 3.27 4.05
Net Sales Growth(%) 0 746.09 39.75 19.06 6.58
EBIT Growth(%) 0 1395.91 107.61 115.71 11.42
PAT Growth(%) 0 738 132.43 222.96 5.47
EPS Growth(%) 0 -58.1 132.43 222.48 5.73
Debt/Equity(x) 111.47 4.47 5.63 3.58 3.17
Current Ratio(x) 0.22 0.68 0.91 1.24 2.75
Quick Ratio(x) 0.05 0.52 0.76 1.04 2.54
Interest Cover(x) 3.84 1.87 1.75 3 2.77
Total Debt/Mcap(x) 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +8% +21% — —
Operating Profit CAGR +15% +55% — —
PAT CAGR +20% +82% — —
Share Price CAGR — — — —
ROE Average +39% +43% +41% +41%
ROCE Average +20% +19% +14% +14%

ABH Healthcare Peer Comparison

Hospital & Healthcare Services Edit Columns

ABH Healthcare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

ABH Healthcare Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 43%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Debtor days have increased from 220.05 to 241.61days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp